Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRW14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,877
Award facts
- Contract value 100% obligated
- $1,876.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,876.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This non-set-aside contract represents performance through August 7, 2025, with delivery to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The award is issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through competitive awards with the Defense Logistics Agency and its Medical Supply Chain. The company demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This particular vaccine delivery order reflects the company's ongoing role as a critical vendor within the federal medical supply chain, supplying essential immunization products to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FRW14?
SPE2DB25FRW14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FRW14 worth?
The government has obligated $1,877 on SPE2DB25FRW14.
Is contract SPE2DB25FRW14 an order under another contract?
Yes. SPE2DB25FRW14 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRW14 competed?
The extent of competition for SPE2DB25FRW14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award